SELECTA BIOSCIENCES INC (SELB) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:SELB • US8162121045

0.8812 USD
-0.08 (-8%)
At close: Nov 13, 2023
0.9 USD
+0.02 (+2.13%)
After Hours: 11/13/2023, 8:15:05 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SELB. SELB was compared to 525 industry peers in the Biotechnology industry. SELB has a bad profitability rating. Also its financial health evaluation is rather negative. SELB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year SELB has reported negative net income.
  • SELB had a negative operating cash flow in the past year.
SELB Yearly Net Income VS EBIT VS OCF VS FCFSELB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 20M -20M -40M -60M

1.2 Ratios

  • SELB has a Return On Assets of -25.12%. This is in the better half of the industry: SELB outperforms 77.33% of its industry peers.
  • SELB's Return On Equity of -53.55% is fine compared to the rest of the industry. SELB outperforms 63.67% of its industry peers.
Industry RankSector Rank
ROA -25.12%
ROE -53.55%
ROIC N/A
ROA(3y)-12.13%
ROA(5y)-47.76%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SELB Yearly ROA, ROE, ROICSELB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 500 -500 1K

1.3 Margins

  • SELB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SELB Yearly Profit, Operating, Gross MarginsSELB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 -10K -20K -30K

More info and screens

3

2. Health

2.1 Basic Checks

  • SELB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for SELB has been increased compared to 1 year ago.
  • Compared to 1 year ago, SELB has an improved debt to assets ratio.
SELB Yearly Shares OutstandingSELB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M
SELB Yearly Total Debt VS Total AssetsSELB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

2.2 Solvency

  • SELB has an Altman-Z score of -3.16. This is a bad value and indicates that SELB is not financially healthy and even has some risk of bankruptcy.
  • SELB has a Altman-Z score of -3.16. This is comparable to the rest of the industry: SELB outperforms 44.33% of its industry peers.
  • A Debt/Equity ratio of 0.21 indicates that SELB is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.21, SELB is doing worse than 69.83% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z -3.16
ROIC/WACCN/A
WACC11.18%
SELB Yearly LT Debt VS Equity VS FCFSELB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 50M -50M

2.3 Liquidity

  • A Current Ratio of 4.18 indicates that SELB has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 4.18, SELB is in line with its industry, outperforming 42.67% of the companies in the same industry.
  • A Quick Ratio of 4.18 indicates that SELB has no problem at all paying its short term obligations.
  • SELB has a Quick ratio (4.18) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 4.18
Quick Ratio 4.18
SELB Yearly Current Assets VS Current LiabilitesSELB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

More info and screens

2

3. Growth

3.1 Past

  • The earnings per share for SELB have decreased strongly by -237.50% in the last year.
  • The Revenue for SELB has decreased by -61.85% in the past year. This is quite bad
  • Measured over the past years, SELB shows a very strong growth in Revenue. The Revenue has been growing by 250.30% on average per year.
EPS 1Y (TTM)-237.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-216.67%
Revenue 1Y (TTM)-61.85%
Revenue growth 3Y155.01%
Revenue growth 5Y250.3%
Sales Q2Q%-86.63%

3.2 Future

  • SELB is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -28.87% yearly.
  • The Revenue is expected to decrease by -11.85% on average over the next years. This is quite bad
EPS Next Y-228.11%
EPS Next 2Y-62.59%
EPS Next 3Y-34.35%
EPS Next 5Y-28.87%
Revenue Next Year-72.53%
Revenue Next 2Y-37.57%
Revenue Next 3Y-26.62%
Revenue Next 5Y-11.85%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SELB Yearly Revenue VS EstimatesSELB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
SELB Yearly EPS VS EstimatesSELB Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -1 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SELB. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SELB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SELB Price Earnings VS Forward Price EarningsSELB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SELB Per share dataSELB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

  • A cheap valuation may be justified as SELB's earnings are expected to decrease with -34.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-62.59%
EPS Next 3Y-34.35%

More info and screens

0

5. Dividend

5.1 Amount

  • SELB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SELECTA BIOSCIENCES INC / SELB FAQ

What is the fundamental rating for SELB stock?

ChartMill assigns a fundamental rating of 2 / 10 to SELB.


What is the valuation status for SELB stock?

ChartMill assigns a valuation rating of 0 / 10 to SELECTA BIOSCIENCES INC (SELB). This can be considered as Overvalued.


What is the profitability of SELB stock?

SELECTA BIOSCIENCES INC (SELB) has a profitability rating of 1 / 10.